Paul Michel Georges Vanhoutte

Title: Paul Michel Georges Vanhoutte: Innovator in Eye Disease Treatment

Introduction

Paul Michel Georges Vanhoutte is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of eye diseases. His innovative approach combines chemistry and medicine to develop effective solutions for patients.

Latest Patents

Vanhoutte holds 1 patent for his invention titled "Diazene-bridge crown ether lithium compounds and methods for their use." This invention provides a method for treating an eye disease in a patient by utilizing a photosensitive prodrug that releases an active ingredient upon exposure to light. The method involves administering the prodrug in a pharmaceutically accepted vehicle and exposing the patient's eye to an external light source to activate the treatment. Additionally, the invention includes a composition for treating glaucoma, which comprises a compound containing a lithium ion chelated in a crown ether or aza-crown ether-containing chromene or diazene derivative, along with a pharmaceutically acceptable carrier.

Career Highlights

Vanhoutte is affiliated with The University of Hong Kong, where he continues to engage in research and development in the field of pharmaceuticals. His work has the potential to significantly impact the treatment of eye diseases, providing new hope for patients suffering from conditions such as glaucoma.

Collaborations

Some of Vanhoutte's notable coworkers include Chi-Ming Che and Kwok-Fai So. Their collaborative efforts contribute to the advancement of research and innovation in the pharmaceutical field.

Conclusion

Paul Michel Georges Vanhoutte is a distinguished inventor whose work in eye disease treatment exemplifies the intersection of chemistry and medicine. His innovative patent offers promising solutions for patients, showcasing the importance of research and collaboration in advancing healthcare.